FDA Approved: VYNDAMAX — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved the original application for VYNDAMAX (TAFAMIDIS) from Pfizer Laboratories Div Pfizer Inc for the treatment of transthyretin amyloidosis with cardi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis with Cardiomyopathy

Drugs mentioned

• Vyndamax (tafamidis)

Snippet

ORIG AP for VYNDAMAX (TAFAMIDIS)